Journal of Clinical Endocrinology & Metabolism, Vol 77, 86-89, Copyright © 1993 by Endocrine Society

ARTICLES

de novo mutation causes steroid 21-hydroxylase deficiency in one family of HLA-identical affected and unaffected siblings

T Tajima, K Fujieda and Y Fujii-Kuriyama
Department of Chemistry, Faculty of Science, Tohoku University, Sendai, Japan.

Over 90% of congenital adrenal hyperplasia (CAH) results from 21- hydroxylase deficiency. Because the CYP21B gene is located within the HLA complex and is very tightly linked to HLA markers, HLA typing is widely used for prenatal diagnosis and identifying heterozygous family members. In the course of a study on identification of heterozygous family members with HLA typing, we recognized an unusual family case in which three siblings share the same HLA haplotype, and only one of them had the simple virilizing form; her two siblings did not have any endocrinological abnormalities. We investigated the mode of genetic transmission by using polymerase chain reaction and single stranded conformation polymorphism. The present study revealed that the proband was a compound heterozygote with the intron 2 mutation that causes aberrant RNA splicing and the missense mutation of exon 4, while the other siblings and the father had only one allele of a missense mutation in exon 4; the mother is a normal homozygote. This result together with DNA fingerprint analysis strongly suggest that the intron 2 mutation occurred de novo in the maternally inherited gene of the proband. This seems to be the first case of a de novo mutation of the CYP21B gene that causes CAH.

This article has been cited by other articles:

				P. F.J. Koppens, T. Hoogenboezem, and H. J. Degenhart Carriership of a defective tenascin-X gene in steroid 21-hydroxylase deficiency patients: TNXB -TNXA hybrids in apparent large-scale gene conversions Hum. Mol. Genet., October 2, 2002; 11(21): 2581 - 2590. [Abstract] [Full Text] [PDF]